The role of thromboprophylaxis in cancer patients: emerging data. - Wikidata - wikimedia - TriplyDB

The role of thromboprophylaxis in cancer patients: emerging data.

The role of thromboprophylaxis in cancer patients: emerging data.

http://www.wikidata.org/entity/Q33625063

about

Pancreatic cancer and thromboembolic disease, 150 years after Trousseau Portal venous system thrombosis after pancreatic resection.

P2860

Q26775634-0A32915C-30E0-4FFD-9078-54F0A542BF24 Q40274920-458F0D28-9BA9-47CB-944B-3B9EEE956F51

P2860

The role of thromboprophylaxis in cancer patients: emerging data.

http://www.wikidata.org/entity/Q33625063

description

2010 nî lūn-bûn

@nan

2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

The role of thromboprophylaxis in cancer patients: emerging data.

@ast

The role of thromboprophylaxis in cancer patients: emerging data.

@en

type

label

The role of thromboprophylaxis in cancer patients: emerging data.

@ast

The role of thromboprophylaxis in cancer patients: emerging data.

@en

prefLabel

The role of thromboprophylaxis in cancer patients: emerging data.

@ast

The role of thromboprophylaxis in cancer patients: emerging data.

@en

P1433

Q33625063-4783AA41-D041-439A-BEBF-7C4728C2D9E2

P1476

Q33625063-248C9744-2E5C-4BCF-968C-E1A16C75BEA0

P2093

Q33625063-5B061FB4-27CD-4E52-B868-2DA1EEC5387D

Q33625063-EC5A5B35-C01F-4AEE-9E14-A373582F69E8

P2860

Q33625063-0D7C5703-4061-49E4-9888-647D60FACE44

Q33625063-10755593-397D-4E21-8E9D-116B26D9CCF6

Q33625063-1347B909-EF2D-44D7-AD90-4ABE73A40B18

Q33625063-151A1855-D6CA-4FAB-B144-04E636B528B6

Q33625063-16EF982E-0876-4D76-822E-041071A75452

Q33625063-1F0A9EAD-D680-47C2-9E48-754CEE2F2591

Q33625063-28FF1683-0BDF-4F22-A3A0-C1674413B883

Q33625063-2E4648C4-C115-475D-9D68-5A6DF8D23EB1

Q33625063-542AE766-6959-41B0-BAC2-79E9865AB554

Q33625063-680C8455-647A-465A-8A0C-019E4AC7160D

P304

Q33625063-56D9D2BD-47AA-4460-A406-C8911702E409

P31

Q33625063-51E49E80-B0F8-4F2F-BAD1-089BC1E2E6DD

P356

Q33625063-11720DEB-BE2C-4783-BA5B-BF456150E088

P433

Q33625063-5A6CFF38-16B8-406C-8EE0-7C413253281D

P478

Q33625063-E84C6015-1A3B-4594-9848-1B45EDCF3E6B

P50

Q33625063-1D447FEA-906F-45C5-AA80-FE1E55815E77

Q33625063-414E9F7B-B58C-4DDF-AB15-D310F7067C75

P577

Q33625063-BC22027A-3173-405A-A0D3-812DA0F0BEFC

P698

Q33625063-D984647D-E3F5-425F-A92F-8F813E2D5E0F

P932

Q33625063-028F9330-D38F-493A-9AAB-2E4A01E7479F

P356

MOH.0B013E32833C0760

P1433

Current Opinion in Hematology

P1476

The role of thromboprophylaxis in cancer patients: emerging data

@en

P2093

Alok A Khorana

http://www.w3.org/2001/XMLSchema#string

Laurel A Menapace

http://www.w3.org/2001/XMLSchema#string

P2860

Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab

Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data.

Rationale and design of PROSPECT-CONKO 004: a prospective, randomized trial of simultaneous pancreatic cancer treatment with enoxaparin and chemotherapy).

Thromboembolism in patients with advanced gastroesophageal cancer treated with anthracycline, platinum, and fluoropyrimidine combination chemotherapy: a report from the UK National Cancer Research Institute Upper Gastrointestinal Clinical Studies Gr

Venous thromboembolism in the outpatient setting

Development and validation of a predictive model for chemotherapy-associated thrombosis.

American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer.

Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma.

Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia.

Risk of venous thromboembolism with the angiogenesis inhibitor bevacizumab in cancer patients: a meta-analysis.

P304

450-456

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MOH.0B013E32833C0760

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P50

Laurel A Menapace

P577

2010-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20601873

http://www.w3.org/2001/XMLSchema#string

P932

3088308

http://www.w3.org/2001/XMLSchema#string